Lecture Vaccines Launch Facility of Janssen Biologics
Are you curious about the Vaccines Launch Facility of Janssen Biologics & Janssen Vaccines and how to get a corona (or HIV, or RSV, or Ebola, etc.) vaccine into production and how the production process works? Then join us at the online zoom lunch lecture on May 20th! The lecture will take place from 12:30 until 13:45. There will be a possibility for questions during/after the lecture.
Janssen is a Pharmaceutical Company of Johnson & Johnson, working tirelessly to fight sickness with science, improving access with ingenuity, and healing hopelessness with heart. They focus on areas of medicine where they can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology and Pulmonary Hypertension.
Janssen is one of the most innovative pharmaceutical companies in the world, with over 36.000 employees and more than 80 medicines. Within the Netherlands over 2100 people work at Janssen in R&D, production and the commercial organization.
Two of the Janssen companies are in Leiden:
– Janssen Vaccines develops vaccines against, amongst others, Ebola, Respiratory Syncytial Virus (RSV), Human Immunodeficiency Virus (HIV) and influenza. 700 Employees work at Janssen Vaccines, of which a substantial amount have a PhD-title. Many different nationalities are represented within the company.
– Janssen Biologics is a worldwide player of emerging importance in health care. They are exploring new paths in developing medicines. Janssen Biologics creates, acquires and brings unique biopharmaceutical medicines to the market. They build on their leadership position in the development of monoclonal antibodies. The innovative products of Janssen Biologics aim on three important areas: infectious diseases, immunological diseases and cancer.
Topic: Guest Lecture Janssen
Time: May 20, 2020 12:30 PM Amsterdam, Berlin, Rome, Stockholm, Vienna
Meeting ID: 977 6942 6132